Optimization of cyclosporine therapy in liver transplantation

Transplantation Proceedings

Volumn 30, Issue 5, 1998, Pages 1816-1818

  Pollard, S G ^a   Lodge, J P A ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A;

CLINICAL TRIAL; CONFERENCE PAPER; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG MONITORING; GRAFT REJECTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NEPHROTOXICITY; NEUROTOXICITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; CLINICAL TRIALS; CYCLOSPORINE; DRUG MONITORING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION;

EID: 0031657376     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)00443-6     Document Type: Conference Paper

References (15)

1. Beverdige T, Gratwohl A, Michot F, et al: Curr Ther Res 30:5, 1981
2. Muller R: Transplantation 58:155, 1994
3. Lindholm A, Kahan BD: Clin Pharmacol Ther 54:208, 1993
4. Batiuk TD, Pazderka F, Enns J, et al: J Clin Invest 96:1254, 1995
5. Grant DR, Kneteman NM, Tchervenkov, et al: Transplantation (in press)
6. Vonderscher J, Meinzer A: Transplant Proc 26:2925, 1994
7. Freeman D, Grant D, Levy GA, et al: Ther Drug Monit 17:213, 1995
8. Trull AK, Tan KKC, Uttrdige J, et al: Lancet 341:433, 1993
9. Superina RA, Strong DK, Acal LA, et al: Transplant Proc 26:2979, 1994
10. Pollard SG, Lodge JPA: Transplant Proc 28:2244, 1996
11. Graziadei IW, Weisner RH, Marotta PJ, et al: Transplantation 64:726, 1997
12. Mirza DF, Gunson BK, Soonawalla Z, et al: Lancet 349:701, 1997
13. Hemming AW, Greig PD, Cattral MS: Transplant Proc 29:543, 1997
14. Rasmussen A, Horrtup A, Hansen BA, et al: Transplantation (in press)
15. Tredger M: Ther Drug Monit 17:638, 1995